"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”

“The team of Professional Services that I work with is very intelligent and collaborative We enjoy working with Medidata, it’s a great team. They’re always willing to come to the table and discuss our needs.”

“By using a system - that both the pharmaceutical industry recognizes, and the regulators accept - to execute high quality clinical trials, our mission to bring better treatments to patients faster can, ultimately, be realized.”

“We’re investing in technology to help us unlock cancer’s secrets, and Medidata’s cloud-based platform provides us with the flexibility and scalability we need to accelerate progress.”

“A shared culture is the key to any successful partnership – Medidata’s commitment to integrity and to putting the client at the center of its work aligns perfectly with palleos’ values.”

“Medidata is a valued and trusted partner. We use a range of their solutions which have allowed us to manage various unique and complex study requirements without having to use custom programming. This has ensured consistent and efficient trial execution.”

“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

"Adopting Medidata's machine-learning capabilities for centralized monitoring will not only put us in line with the updated ICH E6 R2 guidelines, but will also allow us to view clinical information at a more holistic level, better prioritize trial resources, and maintain data quality and integrity."

"When compared with traditional cardiovascular trials that engage hundreds or thousands of sites, this technology allowed us to enroll 15,000 participants from 40 centers. We think this infrastructure and approach will facilitate studies that can be direct-to-patient, easier for patients and investigators, and faster to completion."

“Visibility into patient reporting helps us mitigate protocol compliance issues early in the study rather than later, when it’s harder.”

“Medidata AI literally rolled up their sleeves, helped us analyze the data, and suggested ways to improve our clinical trial design. They were essentially part of our statistical group. We worked with Medidata and leveraged that information when we went to the FDA.”

”Having the RTSM, Coder, and Rave EDC, all [on] one platform makes the integration much more seamless…My reason why I would suggest using Medidata is that the service has been great. The response time has been fantastic, and I always know exactly who to go to if an issue arises …